Eczema creams have different jobs: moisturisers, steroids and alternatives
An eczema moisturiser, topical corticosteroid and topical calcineurin inhibitor are not stronger and weaker versions of one cream. Moisturisers support the skin barrier, while anti-inflammatory medicines treat active inflammation through different pathways. The correct tube also depends on diagnosis, body site, age, severity, formulation and how long the treatment is intended to be used.
Key takeaways
- Moisturisers are baseline barrier care; they do not replace an anti-inflammatory medicine during every flare.
- Topical steroids vary by potency and formulation. The percentage on the tube does not reliably rank different ingredients, and thin-skin sites need particular care.
- Tacrolimus and pimecrolimus are steroid-sparing calcineurin inhibitors used in selected situations, not universal first-line upgrades.
What job does a moisturiser do?
Eczema involves a disrupted skin barrier that loses water and reacts more readily to irritants. Moisturisers, also called emollients, help retain water, reduce dryness and support the barrier. Singapore HealthHub’s eczema guidance recommends regular moisturising as part of ongoing care, including between flares.
The most acceptable product is often the one that can be used consistently without stinging or causing contact irritation. Ointments are greasier and more occlusive; creams and lotions may be easier in other settings. Fragrance and a long ingredient list do not make a product more therapeutic.
A moisturiser does not directly answer how to suppress a significant inflammatory flare. Conversely, an anti-inflammatory medicine should not automatically be spread as an all-purpose moisturiser. If both are prescribed, follow the clinician’s or product’s instructions about order and spacing rather than mixing them together in one container.
Why does topical-steroid potency matter more than the word “steroid”?
Topical corticosteroids reduce inflammation, redness and itch. Singapore HealthHub’s topical-steroid guide stresses applying the selected product to affected skin according to its label. Too little may fail to control inflammation; too much or inappropriate prolonged use increases adverse-effect risk.
Potency is determined by the ingredient and formulation, not by comparing printed percentages across unrelated products. A lower percentage of one ingredient can be more potent than a higher percentage of another. Cream, ointment, lotion and scalp preparations also behave differently.
| Treatment role | Main question | Common comparison error |
|---|---|---|
| Moisturiser/emollient | Is the barrier product tolerated and practical for regular use? | Expecting it to suppress every inflamed flare alone |
| Topical corticosteroid | Is the potency, site, formulation and intended duration appropriate? | Ranking different steroids by percentage only |
| Tacrolimus ointment | Is a steroid-sparing anti-inflammatory appropriate for this site and severity? | Treating it as a moisturiser or stronger steroid |
| Pimecrolimus cream | Does its licensed and clinician-selected role fit the patient? | Assuming tacrolimus and pimecrolimus are interchangeable |
Face, eyelids, folds and genital skin absorb medicines differently from thicker skin on palms or soles. Children also have a different surface-area-to-body-size relationship. This is why an old tube prescribed for one body site should not be reassigned to another without checking.
When are tacrolimus or pimecrolimus discussed?
Tacrolimus and pimecrolimus reduce skin inflammation without being corticosteroids. NICE recommends them as selected second-line options within their licensed indications when appropriate topical corticosteroid treatment has not controlled eczema or further steroid exposure poses an important risk.
They are not interchangeable merely because both are calcineurin inhibitors. Strengths, age restrictions, severity and body-site roles differ. Burning, warmth or stinging can occur early in treatment. HealthHub provides separate Singapore medicine guidance for topical tacrolimus and pimecrolimus, including infection and sun-exposure precautions.
Do not use these products continuously, under occlusion or on a suspected infection unless the prescriber has given that exact instruction. Avoid extrapolating from oral tacrolimus, which is a different systemic treatment.
Why can the wrong diagnosis make a cream look ineffective?
Fungal infection, contact dermatitis, psoriasis, scabies and other conditions can resemble eczema. A steroid may temporarily reduce redness while allowing an infection to spread or changing its appearance. The steroid-creams and fungal-rashes guide explains why hidden steroid-antifungal combinations are particularly difficult to self-compare.
Possible secondary infection includes new weeping, pustules, crusting, rapidly worsening redness, fever or feeling unwell. NICE advises that underlying eczema still needs appropriate care while infection is assessed; antibiotics are not automatically required for every weeping flare.
Painful rapidly spreading areas or clusters of blisters, especially near the eyes, need prompt assessment because eczema herpeticum and other infections can become urgent.
What changes the answer?
- Body site. Face, eyelids, folds, hands, scalp and widespread body eczema do not use one potency/formulation strategy.
- Age and surface area. Infants and children require product- and age-specific instructions.
- Severity and frequency. Occasional small flares and frequent extensive disease call for different review thresholds.
- Infection or a mimic. Crusting, blisters, pain, ring-shaped spread or treatment failure should prompt diagnostic review.
- Pregnancy or breastfeeding. Check the exact product, treated area and exposure with a healthcare professional.
- Previous response and adverse effects. Skin thinning, stretch marks, easy bruising, persistent burning or worsening after application need review.
When should eczema be medically reviewed?
Arrange assessment if the diagnosis is uncertain, eczema is extensive or repeatedly disrupts sleep, treatment used as directed is not working, or frequent potent treatment seems necessary. Prompt care is needed for rapidly spreading redness, significant pain, fever, pus, extensive crusting, clustered blisters, eye involvement or a child who appears unwell.
Bring every tube rather than relying on colour or packaging. Record which area each product was prescribed for and when it was opened. The eczema condition page, atopic dermatitis page and skin-care category can help organise the terminology before a pharmacist or clinician checks the actual products.
Sources
- Singapore HealthHub: Eczema.
- Singapore HealthHub: Topical Steroids.
- Singapore HealthHub: Tacrolimus (topical).
- Singapore HealthHub: Pimecrolimus.
- American Academy of Dermatology: Atopic dermatitis clinical guideline.
- NICE: Tacrolimus and pimecrolimus for atopic eczema.
